Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management
NCT00709787 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 899
Last updated 2021-01-27
Summary
To assess the pattern of hypertension in the population in terms of presence of additional risk factors (ARF) and cardiovascular risk stratification.
Conditions
Interventions
- OTHER
-
Usual Care
Normal care for hypertensive patients with risk factors for CHD
Sponsors & Collaborators
-
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-06-30
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
Countries
- Croatia
- Czechia
Study Locations
More Related Trials
-
Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)
NCT03249285 ·Status: UNKNOWN ·Phase: PHASE3
-
Analysis of Antihypertensive Treatment Efficacy
NCT00767247 ·Status: TERMINATED
-
Nijmegen Antihypertensive Management Improvement Study
NCT00457483 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension
NCT02603809 ·Status: COMPLETED ·Phase: PHASE2
-
Emerging Biomarkers in Hypertension
NCT02064218 ·Status: UNKNOWN
-
Observational Study of the Prognosis in Treated Arterial Hypertension
NCT00225030 ·Status: COMPLETED
-
Monitoring of the Influence of Approved PH-therapies RV-PA Coupling
NCT05935865 ·Status: RECRUITING
-
The TARGET BP OFF-MED Trial
NCT03503773 ·Status: COMPLETED ·Phase: PHASE2
-
Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension
NCT02202525 ·Status: COMPLETED
-
The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
NCT04190420 ·Status: ENROLLING_BY_INVITATION
-
Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy
NCT03832660 ·Status: COMPLETED ·Phase: PHASE2
-
National Survey on Hypertension at Hospital
NCT00695266 ·Status: COMPLETED
-
Renal Denervation for Management of Drug-Resistant Hypertension
NCT01505010 ·Status: COMPLETED ·Phase: NA
-
Systolic Hypertension in Europe Placebo-Controlled Trial
NCT02088450 ·Status: TERMINATED ·Phase: PHASE2
-
Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension
NCT07294794 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
National Survey on Hypertension
NCT00804167 ·Status: COMPLETED
-
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
NCT02558023 ·Status: TERMINATED ·Phase: PHASE3
-
Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension
NCT03078244 ·Status: COMPLETED
-
National Survey on Hypertension in Cardiologic Private Practice
NCT00695175 ·Status: COMPLETED
-
Longitudinal Studies of Blood Pressure in the Elderly
NCT00005409 ·Status: COMPLETED
-
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage
NCT00687206 ·Status: COMPLETED ·Phase: PHASE4
-
Correlates and Control of Blood Pressure Variability
NCT06012487 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives
NCT00005417 ·Status: COMPLETED
-
Knowledge of Vascular Age Contributes to Improve the Collaboration Between Community Pharmacies and Primary Health Care Physicians in Reducing Blood Pressure in Hypertensive Patients.
NCT06761235 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
NCT05732727 ·Status: RECRUITING ·Phase: PHASE3